Product correctly added to cart.

discount label
MKC8866
View 3D

Biosynth logo

MKC8866

CAS: 1338934-59-0

Ref. 3D-NDC93459

1mg
164.00 €
2mg
280.00 €
5mg
556.00 €
10mg
954.00 €
25mg
2,019.00 €
Estimated delivery in United States, on Tuesday 10 Dec 2024

Product Information

Name:
MKC8866
Description:

MKC8866 is an experimental anti-cancer drug that is currently in Phase II clinical trials. It has been shown to inhibit autophagy, which is the process of breaking down and recycling cellular components. This drug has also been shown to reduce protein synthesis and induce apoptosis in cancer cells. The effective dose for MKC8866 has not yet been determined, but it is expected to be between 0.5 and 1 milligrams per kilogram. MKC8866 has also been shown to have anticancer effects on a range of cancers including breast cancer, prostate cancer, lung cancer, ovarian cancer, pancreatic cancer, colon cancer, and gastric cancer.

Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
Biosynth
Long term storage:
Notes:

Chemical properties

Molecular weight:
361.35 g/mol
Formula:
C18H19NO7
Purity:
Min. 95%
Color/Form:
Powder
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:

Hazard Info

UN Number:
EQ:
Class:
H Statements:
P Statements:
Forbidden to fly:
Hazard Info:
Packing Group:
LQ:

Technical inquiry about: 3D-NDC93459 MKC8866

Please use instead the cart to request a quotation or an order

If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.

* Mandatory fields.
Welcome to CymitQuimica!We use cookies to enhance your visit. We do not include advertising.

Please see our Cookies Policy for more details or adjust your preferences in "Settings".